LINDA TRENTHAM: Open Payments
NPI 1902478118 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 18 payments from 8 companies in 2025. Trend: 2023 $1,027 · 2024 $652 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $189 |
| Otsuka America Pharmaceutical, Inc. | 2 | $141 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, REXULTI, Qelbree, Auvelity, TRINTELLIX, ARISTADA, INGREZZA.
Industry payments across TN — which companies pay providers there.
